Cardiovascular Signal in Pfizer/BioNTech mRNA vaccine Clinical Trial

We perform a review of the peer reviewed paper, published on 10/2023 in the International Journal of Vaccine Theory, Practice, and Research, that provides a forensic analysis of the BNT162b2 mRNA clinical trials and the timeline of released documents and up to the 6 month mark (after the unblinding), in March 2021.

The excess mortality rate for cardiovascular diseases were already associated to the Covid-19 vaccinations as there was already a clear signal during the Pfizer clinical trials. In their recent paper Michels et. al., provide a forensic analysis of the BNT162b2 mRNA clinical trials, showing that in the clinical trials, after 6-months, 12 subjects died of a cardiac event, 9 of whom were vaccinated and 3 unvaccinated.
Our review of the paper is significant in the context of our work on the analysis of cause of death, as it establishes a direct link between our analysis of deaths due to cardiovascular events in the UK, that uses data from the UK Office for National Statistics (ONS) and the original phase III clinical trials for the Covid-19 mRNA vaccines.